Clene Inc.
NASDAQCLNN heads into its May 8 earnings call riding an FDA-driven momentum spike — the most significant catalyst update in the company's recent history. The FDA news is the story. On May 4, Clene announced the agency approved its proposed data package as sufficient for submission and review of a New Drug Application for CNM-Au8 in ALS — opening a formal accelerated approval pathway for…
Snapshot as of 7 May 2026
CLNN heads into its May 8 earnings call riding an FDA-driven momentum spike — the most significant catalyst update in the company's recent history. The FDA news is the story. On May 4, Clene announced the agency…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLNN — free to start on ORTEX.
Sign up for free →Open CLNN on ORTEX